Source: LeanLife Health Inc.
  • LeanLife Health (LLP) has closed a first tranche of a $1M private placement for proceeds of $365,000
  • The company issued a total of 7,300,000 units at a price of $0.05 per unit 
  • The company intends to use the proceeds for general capital purposes & towards the licensing agreement/product purchase orders with Foodcare
  • LeanLife Health offers high-quality omega3 plant-based oils as well as its line of Iron Energy drinks
  • LeanLife Health (LLP) is unchanged on the day, trading at C$0.04 per share at 1 pm EST

LeanLife Health (LLP) has closed a first tranche of it $1 million private placement for proceeds of $365,000.

The company issued a total of 7,300,000 units at a price of $0.05 per unit. 

Each unit consists of of one common share and one-half a transferrable share purchase warrant. Each whole warrant will entitle the holder to purchase an additional share at a price of $0.075 per for a 2-year period.

All the securities issued are subject to a four month statutory hold period.

The warrants are subject to an acceleration clause.

LeanLife will pay finder’s fees totalling $27,000 in cash, and 540,000 in finders warrants. 

The company intends to use the proceeds for general capital purposes & towards the licensing agreement/product purchase orders with Foodcare.

LeanLife Health offers high-quality omega3 plant-based oils as well as its line of Iron Energy drinks.

LeanLife Health (LLP) is unchanged on the day, trading at C$0.04 per share at 1 pm EST.

More From The Market Online

Canopy Growth fuels turnaround story with fresh capital

Canopy Growth (TSX:WEED) continues its turnaround story with a C$96.3 million exchange and subscription deal with an institutional investor.

Tilray’s 10 Barrel Brewing introduces new Mexican-style lagers

Tilray Brands (TSX:TLRY) subsidiary 10 Barrel Brewing unveils its latest creation: Pub Cerveza, a southern spirit in a Mexican-style lager.

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

One of the strongest contenders to lead Canada’s cannabis market

Indiva Ltd. (TSXV:NDVA) recently reported its fiscal year 2023 results, showcasing a solid performance across its operations.